{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:27:04Z","timestamp":1790486824362,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","nucmedbio.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.nucmedbio.2014.07.005","type":"journal-article","created":{"date-parts":[[2014,7,31]],"date-time":"2014-07-31T23:34:59Z","timestamp":1406849699000},"page":"802-812","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["N-Succinimidyl guanidinomethyl iodobenzoate protein radiohalogenation agents: Influence of isomeric substitution on radiolabeling and target cell residualization"],"prefix":"10.1016","volume":"41","author":[{"given":"Jaeyeon","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesan","family":"Vaidyanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eftychia","family":"Koumarianou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darryl","family":"McDougald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Pruszynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Osada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Lahoutte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Kim","family":"Lyerly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Zalutsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2014.07.005_bb0005","series-title":"Monoclonal serotherapy","author":"Bast","year":"2010"},{"key":"10.1016\/j.nucmedbio.2014.07.005_bb0010","first-page":"2907","article-title":"Intracellular catabolism of radiolabeled anti-mu antibodies by malignant B-cells","volume":"52","author":"Geissler","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2014.07.005_bb0015","first-page":"2123","article-title":"Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells","volume":"56","author":"Press","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2014.07.005_bb0020","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0969-8051(88)80015-5","article-title":"Synthesis and radioiodination of tyramine cellobiose for labeling monoclonal antibodies","volume":"15","author":"Ali","year":"1988","journal-title":"Int J Rad Appl Instrum B"},{"key":"10.1016\/j.nucmedbio.2014.07.005_bb0025","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0883-2897(88)90080-3","article-title":"Residualizing and non-residualizing analogues of low-density lipoprotein as iodine-123 radiopharmaceuticals for imaging LDL catabolism","volume":"15","author":"Moerlein","year":"1988","journal-title":"Int J Rad Appl Instrum B"},{"key":"10.1016\/j.nucmedbio.2014.07.005_bb0030","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/0883-2897(92)90103-6","article-title":"Design of compounds having enhanced tumour uptake, using serum albumin as a carrier\u2013Part II. In vivo studies","volume":"19","author":"Schilling","year":"1992","journal-title":"Int J Rad Appl Instrum B"},{"key":"10.1016\/j.nucmedbio.2014.07.005_bb0035","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1021\/bc980075g","article-title":"Labeling of monoclonal antibodies with diethylenetriaminepentaacetic acid-appended radioiodinated peptides containing D-amino acids","volume":"10","author":"Govindan","year":"1999","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nucmedbio.2014.07.005_bb0040","first-page":"4453","article-title":"Radioiodination via D-amino acid peptide enhances cellular retention and tumor xenograft targeting of an internalizing anti-epidermal growth factor receptor variant III monoclonal antibody","volume":"60","author":"Foulon","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2014.07.005_bb0045","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1021\/bc0600766","article-title":"N\u03b5-(3-[*I]Iodobenzoyl)-Lys5-N\u03b1-maleimido-Gly1-GEEEK ([*I]IB-Mal-D-GEEEK): a radioiodinated prosthetic group containing negatively charged D-glutamates for labeling internalizing monoclonal antibodies","volume":"17","author":"Vaidyanathan","year":"2006","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nucmedbio.2014.07.005_bb0050","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1021\/bc00007a009","article-title":"N-succinimidyl 5-(trialkylstannyl)-3-pyridinecarboxylates: a new class of reagents for protein radioiodination","volume":"2","author":"Garg","year":"1991","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nucmedbio.2014.07.005_bb0055","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0969-8051(93)90149-O","article-title":"Radioiodination of a monoclonal antibody using N-succinimidyl 5-iodo-3-pyridinecarboxylate","volume":"20","author":"Garg","year":"1993","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2014.07.005_bb0060","first-page":"4970","article-title":"Radioiodination of internalizing monoclonal antibodies using N-succinimidyl 5-iodo-3-pyridinecarboxylate","volume":"56","author":"Reist","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2014.07.005_bb0065","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1021\/bc025636p","article-title":"N-succinimidyl 3-[131I]iodo-4-phosphonomethylbenzoate ([131I]SIPMB), a negatively charged substituent-bearing acylation agent for the radioiodination of peptides and mAbs","volume":"14","author":"Shankar","year":"2003","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nucmedbio.2014.07.005_bb0070","doi-asserted-by":"crossref","first-page":"6929","DOI":"10.1016\/j.bmc.2012.10.025","article-title":"SIB-DOTA: a trifunctional prosthetic group potentially amenable for multi-modal labeling that enhances tumor uptake of internalizing monoclonal antibodies","volume":"20","author":"Vaidyanathan","year":"2012","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.nucmedbio.2014.07.005_bb0075","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1021\/bc0001490","article-title":"A polar substituent-containing acylation agent for the radioiodination of internalizing monoclonal antibodies: N-succinimidyl 4-guanidinomethyl-3-[131I]iodobenzoate ([131I]SGMIB)","volume":"12","author":"Vaidyanathan","year":"2001","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nucmedbio.2014.07.005_bb0080","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nprot.2007.20","article-title":"Synthesis of N-succinimidyl 4-guanidinomethyl-3-[*I]iodobenzoate: a radio-iodination agent for labeling internalizing proteins and peptides","volume":"2","author":"Vaidyanathan","year":"2007","journal-title":"Nat Protoc"},{"key":"10.1016\/j.nucmedbio.2014.07.005_bb0085","doi-asserted-by":"crossref","first-page":"650","DOI":"10.2967\/jnumed.113.127100","article-title":"Improved tumor targeting of Anti-HER2 nanobody through N-succinimidyl 4-guanidinomethyl-3-Iodobenzoate radiolabeling","volume":"55","author":"Pruszynski","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2014.07.005_bb0090","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.nucmedbio.2012.08.008","article-title":"Targeting breast carcinoma with radioiodinated anti-HER2 Nanobody","volume":"40","author":"Pruszynski","year":"2013","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2014.07.005_bb0095","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.nucmedbio.2009.04.002","article-title":"Evaluation of an anti-p185(HER2) (scFv-C(H)2-C(H)3)2 fragment following radioiodination using two different residualizing labels: SGMIB and IB-Mal-D-GEEEK","volume":"36","author":"Vaidyanathan","year":"2009","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2014.07.005_bb0100","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0883-2889(89)90131-7","article-title":"Synthesis of radioiodinated N-succinimidyl iodobenzoate: optimization for use in antibody labelling","volume":"40","author":"Garg","year":"1989","journal-title":"Int J Rad Appl Instrum A"},{"key":"10.1016\/j.nucmedbio.2014.07.005_bb0105","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0022-1759(84)90435-6","article-title":"Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess","volume":"72","author":"Lindmo","year":"1984","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.nucmedbio.2014.07.005_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0969-8051(01)00277-3","article-title":"Improved xenograft targeting of tumor-specific anti-epidermal growth factor receptor variant III antibody labeled using N-succinimidyl 4-guanidinomethyl-3-iodobenzoate","volume":"29","author":"Vaidyanathan","year":"2002","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2014.07.005_bb0115","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0969-8051(03)00005-2","article-title":"N-succinimidyl 3-[211At]astato-4-guanidinomethylbenzoate: an acylation agent for labeling internalizing antibodies with alpha-particle emitting 211At","volume":"30","author":"Vaidyanathan","year":"2003","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2014.07.005_bb0120","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/j.peptides.2004.08.018","article-title":"Radioiodine and 211At-labeled guanidinomethyl halobenzoyl octreotate conjugates: potential peptide radiotherapeutics for somatostatin receptor-positive cancers","volume":"25","author":"Vaidyanathan","year":"2004","journal-title":"Peptides"},{"key":"10.1016\/j.nucmedbio.2014.07.005_bb0125","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1093-3263(03)00140-2","article-title":"Computer-aided design of a factor Xa inhibitor by using MCSS functionality maps and a CAVEAT linker search","volume":"22","author":"Takano","year":"2003","journal-title":"J Mol Graph Model"},{"key":"10.1016\/j.nucmedbio.2014.07.005_bb0130","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1021\/jo9704164","article-title":"A new route to guanidines from bromoalkanes","volume":"62","author":"Vaidyanathan","year":"1997","journal-title":"J Org Chem"},{"key":"10.1016\/j.nucmedbio.2014.07.005_bb0140","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1016\/S0040-4039(01)00699-2","article-title":"A photoaffinity probe for 5-hydroxyeicosanoid dehydrogenase suitable for radioiodination","volume":"42","author":"Kim","year":"2001","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.nucmedbio.2014.07.005_bb0145","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/jlcr.1668","article-title":"Large-scale synthesis of no-carrier-added [I-123] mIBG, using two different stannylated precursors","volume":"52","author":"Rossouw","year":"2009","journal-title":"J Labelled Compd Radiopharm"},{"key":"10.1016\/j.nucmedbio.2014.07.005_bb0150","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0969-8043(93)90179-E","article-title":"No-carrier-added synthesis of meta-[131I]iodobenzylguanidine","volume":"44","author":"Vaidyanathan","year":"1993","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2014.07.005_bb0155","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/mc.20212","article-title":"Antitumor activity of an Ets protein, PEA3, in breast cancer cell lines MDA-MB-361DYT2 and BT474M1","volume":"45","author":"Yu","year":"2006","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.nucmedbio.2014.07.005_bb0160","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1089\/cbr.1999.14.209","article-title":"In vivo comparison of CHX-DTPA ligand isomers in athymic mice bearing carcinoma xenografts","volume":"14","author":"Roselli","year":"1999","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.nucmedbio.2014.07.005_bb0165","first-page":"829","article-title":"Evaluation of the in vivo biodistribution of yttrium-labeled isomers of CHX-DTPA-conjugated monoclonal antibodies","volume":"39","author":"Kobayashi","year":"1998","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2014.07.005_bb0170","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/0883-2897(89)90136-0","article-title":"Labeling proteins using aryl iodide acylation agents: influence of meta vs para substitution on in vivo stability","volume":"16","author":"Garg","year":"1989","journal-title":"Int J Rad Appl Instrum B"},{"key":"10.1016\/j.nucmedbio.2014.07.005_bb0175","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1021\/bc100560c","article-title":"Rapid identification of fluorochrome modification sites in proteins by LC ESI-Q-TOF mass spectrometry","volume":"22","author":"Manikwar","year":"2011","journal-title":"Bioconjug Chem"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805114004569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805114004569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T03:25:25Z","timestamp":1538364325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805114004569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0969805114004569"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2014.07.005","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N-Succinimidyl guanidinomethyl iodobenzoate protein radiohalogenation agents: Influence of isomeric substitution on radiolabeling and target cell residualization","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2014.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}